DOI QR코드

DOI QR Code

Anti-diabetic Effects of Ethanol Extract from Bitter Melon in Mice Fed a High-fat Diet

  • Yoon, Nal Ae (Dept. of Anatomy & Convergence Medical Science, College of Medicine, Gyeongsang National University) ;
  • Park, Juyeong (Dept. of Anatomy & Convergence Medical Science, College of Medicine, Gyeongsang National University) ;
  • Lee, Jiyeon (Dept. of Anatomy & Convergence Medical Science, College of Medicine, Gyeongsang National University) ;
  • Jeong, Joo Yeon (Dept. of Anatomy & Convergence Medical Science, College of Medicine, Gyeongsang National University) ;
  • Kim, Hyun-Kyu (Nutraceutical Food R&D Center, KolmarBNH Co., Ltd.) ;
  • Lee, Hak Sung (Nutraceutical Food R&D Center, KolmarBNH Co., Ltd.) ;
  • Hwang, In Guk (Dept. of Agrofood Resources, National Academy of Agricultural Science, Rural Development Administration) ;
  • Roh, Gu Seob (Dept. of Anatomy & Convergence Medical Science, College of Medicine, Gyeongsang National University) ;
  • Kim, Hyun Joon (Dept. of Anatomy & Convergence Medical Science, College of Medicine, Gyeongsang National University) ;
  • Cho, Gyeong Jae (Dept. of Anatomy & Convergence Medical Science, College of Medicine, Gyeongsang National University) ;
  • Choi, Wan Sung (Dept. of Anatomy & Convergence Medical Science, College of Medicine, Gyeongsang National University) ;
  • Lee, Dong Hoon (Dept. of Anatomy & Convergence Medical Science, College of Medicine, Gyeongsang National University) ;
  • Kang, Sang Soo (Dept. of Anatomy & Convergence Medical Science, College of Medicine, Gyeongsang National University)
  • 투고 : 2017.09.11
  • 심사 : 2017.09.17
  • 발행 : 2017.09.30

초록

Present study aimed to determine the effect of 'bitter melon', a popularly used fruit in Bangladesh and several other Asian countries, on high-fat-diet-induced type 2 diabetes. To investigate the effect, ethanol extract from bitter melon (BME) as a dietary supplement with mouse chow was used. BME was found to significantly attenuate the high-fat diet (HFD) -induced body weight and total fat mass. BME also effectively reduced the insulin resistance induced by the HFD. Furthermore, dietary supplementation of BME was highly effective in increasing insulin sensitivity and reducing hepatic fat and obesity. These results indicate that BME could be effective in attenuating type 2 diabetes and could therefore be a preventive measure against type 2 diabetes.

키워드

참고문헌

  1. Agrawal S (2016) Role of self- Care in management of diabetes mellitus. J Assoc Physicians India 64:92.
  2. Alam MA, Uddin R, Subhan N, Rahman MM, Jain P, Reza HM (2015) Beneficial role of bitter melon supplementation in obesity and related complications in metabolic syndrome. J Lipids 2015: 496169.
  3. Bray GA, Jablonski KA, Fujimoto WY, Barrett-Connor E, Haffner S, Hanson RL, Hill JO, Hubbard V, Kriska A, Stamm E, Pi-Sunyer FX (2008) Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. Am J Clin Nutr 87:1212-1218. https://doi.org/10.1093/ajcn/87.5.1212
  4. Chen Q, Chan LL, Li ET (2003) Bitter melon (Momordica charantia) reduces adiposity, lowers serum insulin and normalizes glucose tolerance in rats fed a high fat diet. J Nutr 133:1088-1093. https://doi.org/10.1093/jn/133.4.1088
  5. De Kreutzenberg SV, Ceolotto G, Papparella I, Bortoluzzi A, Semplicini A, Dalla Man C, Cobelli C, Fadini GP, Avogaro A (2010) Downregulation of the longevityassociated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms. Diabetes 59:1006-1015. https://doi.org/10.2337/db09-1187
  6. Deshpande AD, Harris-Hayes M, Schootman M (2008) Epidemiology of diabetes and diabetes-related complications. Phys Ther 88:1254-1264. https://doi.org/10.2522/ptj.20080020
  7. Efird JT, Choi YM, Davies SW, Mehra S, Anderson EJ, Katunga LA (2014) Potential for improved glycemic control with dietary Momordica charantia in patients with insulin resistance and pre-diabetes. Int J Environ Res Public Health 11: 2328-2345. https://doi.org/10.3390/ijerph110202328
  8. Fulco M, Sartorelli V (2008) Comparing and contrasting the roles of AMPK and SIRT1 in metabolic tissues. Cell Cycle 7: 3669-3679. https://doi.org/10.4161/cc.7.23.7164
  9. Ginsberg HN, Maccallum PR (2009) The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus. J Cardiometab Syndr 4:113-119. https://doi.org/10.1111/j.1559-4572.2008.00044.x
  10. Hu FB, Malik VS (2010) Sugar-sweetened beverages and risk of obesity and type 2 diabetes: epidemiologic evidence. Physiol Behav 100: 47-54. https://doi.org/10.1016/j.physbeh.2010.01.036
  11. Kitada M, Koya D (2013) SIRT1 in type 2 diabetes: mechanisms and therapeutic potential. Diabetes Metab J 37: 315-325. https://doi.org/10.4093/dmj.2013.37.5.315
  12. Lara-Castro C, Garvey WT (2008) Intracellular lipid accumulation in liver and muscle and the insulin resistance syndrome. Endocrinol Metab Clin North Am 37:841-856. https://doi.org/10.1016/j.ecl.2008.09.002
  13. Li X (2013) SIRT1 and energy metabolism. Acta Biochim Biophys Sin (Shanghai) 45:51-60. https://doi.org/10.1093/abbs/gms108
  14. Li X, Kazgan N (2011) Mammalian sirtuins and energy metabolism. Int J Biol Sci 7:575-587. https://doi.org/10.7150/ijbs.7.575
  15. Lo HY, Ho TY, Lin C, Li CC, Hsiang CY (2013) Momordica charantia and its novel polypeptide regulate glucose homeostasis in mice via binding to insulin receptor. J Agric Food Chem 61:2461-2468. https://doi.org/10.1021/jf3042402
  16. Mahmoud MF, El Ashry FE, El Maraghy NN, Fahmy A (2017) Studies on the antidiabetic activities of Momordica charantia fruit juice in streptozotocin-induced diabetic rats. Pharm Biol 55:758-765. https://doi.org/10.1080/13880209.2016.1275026
  17. Mayoral R, Osborn O, Mcnelis J, Johnson AM, Oh DY, Izquierdo CL, Chung H, Li P, Traves PG, Bandyopadhyay G, Pessentheiner AR, Ofrecio JM, Cook JR, Qiang L, Accili D, Olefsky JM (2015) Adipocyte SIRT1 knockout promotes PPARgamma activity, adipogenesis and insulin sensitivity in chronic-HFD and obesity. Mol Metab 4:378-391. https://doi.org/10.1016/j.molmet.2015.02.007
  18. Patel DK, Prasad SK, Kumar R, Hemalatha S (2012) An overview on antidiabetic medicinal plants having insulin mimetic property. Asian Pac J Trop Biomed 2:320-330. https://doi.org/10.1016/S2221-1691(12)60032-X
  19. Pfluger PT, Herranz D, Velasco-Miguel S, Serrano M, Tschop MH (2008) Sirt1 protects against high-fat dietinduced metabolic damage. Proc Natl Acad Sci USA 105:9793-9798. https://doi.org/10.1073/pnas.0802917105
  20. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P (2005) Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434:113-118. https://doi.org/10.1038/nature03354
  21. Ruda-Kucerova J, Kotolova H, Koupy D (2015) Effectiveness of phytotherapy in supportive treatment of type 2 diabetes mellitus III. Momordica (Momordica charantia). Ceska Slov Farm 64:126-132.
  22. Shafiee G, Mohajeri-Tehrani M, Pajouhi M, Larijani B (2012) The importance of hypoglycemia in diabetic patients. J Diabetes Metab Disord 11:17. https://doi.org/10.1186/2251-6581-11-17
  23. Steyn NP, Mann J, Bennett PH, Temple N, Zimmet P, Tuomilehto J, Lindstrom J, Louheranta A (2004) Diet, nutrition and the prevention of type 2 diabetes. Public Health Nutr 7:147-165.
  24. Tan MJ, Ye JM, Turner N, Hohnen-Behrens C, Ke CQ, Tang CP, Chen T, Weiss HC, Gesing ER, Rowland A, James DE, Ye Y (2008) Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway. Chem Biol 15:263-273. https://doi.org/10.1016/j.chembiol.2008.01.013
  25. Unger RH (2003) Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 144:5159-5165. https://doi.org/10.1210/en.2003-0870
  26. Walker AK, Yang F, Jiang K, Ji JY, Watts JL, Purushotham A, Boss O, Hirsch ML, Ribich S, Smith JJ, Israelian K, Westphal CH, Rodgers JT, Shioda T, Elson SL, Mulligan P, Najafi-Shoushtari H, Black JC, Thakur JK, Kadyk LC, Whetstine JR, Mostoslavsky R, Puigserver P, Li X, Dyson NJ, Hart AC, Naar AM (2010) Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP. Genes Dev 24:1403-1417. https://doi.org/10.1101/gad.1901210
  27. Wang G, Zhang Z, Feng Y, Sun L, Xiao X, Wang G, Gao Y, Wang H, Zhang H, Deng Y, Sun C (2017) Telemedicine in the management of type 2 diabetes mellitus. Am J Med Sci 353:1-5. https://doi.org/10.1016/j.amjms.2016.10.008